0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

The Treatment of Clostridium difficile Colitis

Gregory M. Caputo, MD; Michael R. Weitekamp, MD
JAMA. 1993;269(16):2088. doi:10.1001/jama.1993.03500160054029.
Text Size: A A A
Published online

To the Editor.  —We applaud the recent Editorial by Drs Spera and Farber,1 which should increase awareness of the growing problem of multiply-resistant Enterococcus faecium. We agree that limitation of the use of antimicrobial agents that select for growth of these strains should be a major element of infection control practice. However, one of their specific recommendations deserves further comment. They state that "oral metronidazole should become the treatment of choice for colitis due to Clostridium difficile since it has efficacy equal to that of oral vancomycin and is much more cost-effective."We believe that metronidazole has an important role in the treatment of mildly to moderately ill patients with C difficile colitis. The largest prospective, randomized trial to date of metronidazole vs vancomycin for C difficile—associated diarrhea did show the drugs equally effective in such patients.2 However, only 30% of the patients treated in that study

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

19 Views
0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
×
brightcove.createExperiences();